GlassScriptPhysician profile
Celina Paras
NPI 1891213195
$2,356.98
in general payments reported to CMS, 2019-2025
26 companies · $2,091 in 2025
The $2,091 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $41.07 · 2024: $225 · 2025: $2,091.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,356.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $433.78 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $234.90 | 2025 | Evenity, Tepezza, Repatha |
| Sequel Med Tech, LLC | $219.32 | 2025 | Twiist |
| Xeris Pharmaceuticals, INC. | $166.46 | 2024-2025 | Gvoke Hypopen, Recorlev |
| Mannkind Corporation | $152.54 | 2024-2025 | |
| Lilly USA, LLC | $123.17 | 2025 | Mounjaro, Zepbound, Jardiance |
| Radius Health, INC. | $116.41 | 2024-2025 | Tymlos |
| Insulet Corporation | $107.59 | 2025 | Omnipod |
| Lexicon Pharmaceuticals, INC. | $106.81 | 2024 | Inpefa |
| Dexcom, INC. | $77.13 | 2023-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $76.26 | 2025 | |
| Corcept Therapeutics | $65.57 | 2025 | Korlym |
| Madrigal Pharmaceuticals | $59.78 | 2025 | Rezdiffra |
| Cequr Corporation | $57.94 | 2025 | Cequr Simplicity |
| Tandem Diabetes Care, INC. | $54.97 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $41.63 | 2025 | Minimed 780g |
| Amneal Pharmaceuticals LLC | $39.27 | 2025 | Unithroid |
| Soleno Therapeutics, INC. | $39.13 | 2025 | Vykat Xr |
| Ascendis Pharma Endocrinology INC | $35.56 | 2025 | Yorvipath |
| Abbvie INC. | $32.42 | 2025 | |
| Beta Bionics, INC. | $24.46 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Exact Sciences Corporation | $20.72 | 2023 | Cologuard Collection Kit |
| Ascensia Diabetes Care US INC. | $19.04 | 2025 | |
| Antares Pharma, INC. | $18.01 | 2024 | Xyosted |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.80 | 2025 | Jardiance |
| Rhythm Pharmaceuticals, INC. | $16.31 | 2024 | Imcivree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Celina Paras listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.